Bristol Myers Squibb (BMS) is a global Fortune 500 biopharmaceutical company committed to discovering, developing, and delivering innovative medicines for patients with serious diseases. BMS focuses on oncology, immunology, cardiovascular, fibrosis, and cell therapy (CAR T). - View it on GitHub